- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PDA001
Total 477 results
-
Novartis PharmaceuticalsCompletedRenal TransplantationSwitzerland
-
Washington University School of MedicineTyrogenexTerminatedAdenocarcinoma | Pancreatic NeoplasmsUnited States
-
Kathleen DunganNovo Nordisk A/SCompletedDiabetes | Admitting Hospital | Non-critically IllUnited States
-
Novartis PharmaceuticalsCompletedCarcinoid Tumor | Malignant Carcinoid SyndromeFrance, Spain, Netherlands, United States, Canada, Sweden, Italy, Australia, Germany, Greece, Belgium, Czech Republic, Slovakia, Finland, United Kingdom
-
Novartis PharmaceuticalsTerminatedMetastatic Pancreatic Ductal AdenocarcinomaBelgium, Finland, Taiwan, Australia, Germany, Spain, Italy, Austria, Czechia, Switzerland, Singapore, United Kingdom, United States, France
-
TakedaCompletedA Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionPediatric HypertensionJapan
-
Massachusetts General HospitalMemorial Sloan Kettering Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute and other collaboratorsCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBayer; NovartisCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicSpain, Italy, Czechia, Malaysia, Turkey, China, United States, Greece, Brazil
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital and other collaboratorsCompletedPancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Emory UniversityTerminated
-
Dana-Farber Cancer InstituteNovartis; Millennium Pharmaceuticals, Inc.TerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
University of California, San FranciscoNovartisCompleted
-
Novartis PharmaceuticalsTerminated
-
Asan Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
University of California, DavisNovartisCompletedProstate CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
HK inno.N CorporationCompleted
-
Federico II UniversityCompletedMedullary Thyroid CancerItaly
-
Herbert HurwitzGenentech, Inc.; Novartis PharmaceuticalsCompletedColorectal AdenocarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
Yale UniversityNovartisCompletedEndometrial CancerUnited States
-
M.D. Anderson Cancer CenterNovartis; Genentech, Inc.CompletedNeuroendocrine CarcinomaUnited States
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.TerminatedIntracranial MeningiomaUnited States
-
University of California, San FranciscoGenentech, Inc.; Novartis Pharmaceuticals; The V Foundation for Cancer ResearchTerminated
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedHEAD & NECK CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingTuberous Sclerosis ComplexUnited States, Spain, Belgium, Taiwan, Turkey, Australia, Korea, Republic of, Thailand, France, Hungary, United Kingdom, Italy, Japan, Canada, Russian Federation, Poland, Mexico, Colombia
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedSystemic MastocytosisUnited States
-
Emory UniversityNovartisCompletedThyroid CancerUnited States
-
Novartis PharmaceuticalsRecruiting
-
University of Texas Southwestern Medical CenterCompletedRecurrent Childhood EpendymomaUnited States
-
Emory UniversityNovartis; CelgeneCompletedNeuroendocrine Tumors | Solid Organ Malignancies | Adenoidcystic CarcinomaUnited States
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.CompletedKidney CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia | Myelofibrosis | Mantle Cell LymphomaUnited States
-
University of California, San FranciscoNovartisTerminatedLow Grade Glioma | World Health Organization (WHO) Grade II Astrocytomas | Oligodendrogliomas | Mixed OligoastrocytomasUnited States
-
The Methodist Hospital Research InstituteNovartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States
-
SCRI Development Innovations, LLCBayer; NovartisCompletedKidney CancerUnited States
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.Completed
-
Sandy SrinivasNovartis; Genentech, Inc.TerminatedKidney Neoplasms | Kidney (Renal Cell) CancerUnited States
-
Krankenhaus NordwestCompletedAdvanced Gastric Cancer | Esophagogastric Junction CancerGermany
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedEverolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaUnited States